All sponsors

Chiesi Farmaceutici S.p.A.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS9
PHASE 3 / 2-37
RECRUITING7
READOUTS ≤12 MONTHS2
Open Chiesi Farmaceutici S.p.A. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
REVIVE
NCT06917690
P3RecruitingEpidermolysis Bullosa; Junctional Epidermolysis Bullosa62026-03
TRECONY
NCT07301736
P2RecruitingAsthma7802027-06-03
RISE
NCT05710692
P2/3RecruitingFabry Disease162027-10 (+19 mo)
Metreleptin
NCT06679270
P3RecruitingFamilial Partial Lipodystrophy242028-03
ZAPPHIRE
NCT07516951
P2RecruitingIdiopathic Pulmonary Fibrosis2402028-06-27
FLY
NCT06328608
P2/3RecruitingFabry Disease222028-10 (+10 mo)
TRICHECO
NCT07546981
P3RecruitingAsthma5542028-10-17
FABLE
NCT07577804
P3Not yet recruitingBronchiectasis9042030-04
TRIADES
NCT07858123
P3Not yet recruitingAsthma7002030-06-26